Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 NULL
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: NUL
  • 52 Week Low: 1.00p
  • Currency: UK Pounds
  • Shares Issued: 1,513.39m
  • Volume: 0
  • RiskGrade: 429
  • Beta: 0.12

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

1 Day Chart (31-07-2025)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -182.9% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3.3 n/a
Pr/Book 2.1  
Latest F'cast
Revenue 229.6% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Verici DX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (4.74) (5.46)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (8.33) (5.90)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (11.41) (6.90)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 1.01 (8.73) (5.10)¢ n/a n/a n/a n/a 0.0%
31-Dec-24 3.34 (5.87) (2.50)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Verici DX Company Announcements

Holding(s) in Company 31-Jul-2025 17:33 RNS
Holding(s) in Company 31-Jul-2025 17:28 RNS
Holding(s) in Company 31-Jul-2025 15:24 RNS

Latest Verici DX Director Deals

Traded Action Notifier PriceAmountValue
24-Jul-25 Placing Ian James Carruthers 0.50p 2,000,000 £10,000.00
24-Jul-25 Placing Sara Barrington 0.50p 4,000,000 £20,000.00
24-Jul-25 Placing Julian Baines 0.50p 4,000,000 £20,000.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Verici DX Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change 0.000p
% Change 0.00 %
52 Week High NUL
52 Week Low 1.00p
Volume 0
Shares Issued 1,513.39m
Beta 0.12
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.65% below the market average30.65% below the market average30.65% below the market average30.65% below the market average30.65% below the market average
21.95% below the sector average21.95% below the sector average21.95% below the sector average21.95% below the sector average21.95% below the sector average
Price Trend
98.98% below the market average98.98% below the market average98.98% below the market average98.98% below the market average98.98% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
24.98% above the market average24.98% above the market average24.98% above the market average24.98% above the market average24.98% above the market average
13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average

Verici DX Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page